Nilsine Partners’s CVS Health CVS Stock Holding History

Nilsine Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$439K	Buy	4,244 +335	+9%	+$29.9K	0.03%	317
2026 Q1	$306K	Sell	3,909 -201	-5%	-$15.5K	0.02%	332
2025 Q4	$326K	Buy	4,110 +502	+14%	+$39.6K	0.03%	321
2025 Q3	$272K	Buy	+3,608	New	+$247K	0.02%	343
2024 Q4	–	Sell	-3,587	Closed	-$226K	–	367
2024 Q3	$226K	Sell	3,587 -1,365	-28%	-$79.6K	0.03%	320
2024 Q2	$292K	Sell	4,952 -4,245	-46%	-$266K	0.04%	280
2024 Q1	$734K	Buy	9,197 +770	+9%	+$58.8K	0.1%	197
2023 Q4	$665K	Sell	8,427 -20	-0.2%	-$1.42K	0.1%	201
2023 Q3	$590K	Buy	8,447 +154	+2%	+$10.9K	0.09%	206
2023 Q2	$573K	Sell	8,293 -1,285	-13%	-$91.4K	0.08%	216
2023 Q1	$712K	Buy	+9,578	New	+$803K	0.11%	191

Other funds holding CVS

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Nilsine Partners's CVS Position: Q2 2026 in Review

Nilsine Partners increased its CVS Health (CVS) stake by 8.6% in Q2 2026, buying an estimated $29.9K and bringing the position to 4,244 shares worth $439K. The position accounts for 0.03% of the portfolio, ranked #317.

Nilsine Partners first reported a position in CVS in Q1 2023 and has held it in 11 quarters since. The position peaked at $734K in Q1 2024. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Nilsine Partners held 4,244 shares of CVS Health worth $439K as of Q2 2026.
Nilsine Partners bought 335 CVS Health shares in Q2 2026, an estimated $29.9K.
CVS Health made up 0.03% of Nilsine Partners's portfolio in Q2 2026, its #317 holding.
Nilsine Partners first reported a position in CVS Health in Q1 2023 and has held it in 11 quarters since.
Nilsine Partners's CVS Health position peaked at $734K in Q1 2024.
650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.